| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |